Oral mucositis in patients with oncological pathology of the oropharyngeal region: review-Reference-Cited by-同舟云学术

Oral mucositis in patients with oncological pathology of the oropharyngeal region: review

Published:2020-11-16 Issue:3 Volume:10 Page:72-80
ISSN:2411-4634
Container-title:Head and Neck Tumors (HNT)
language:
Short-container-title:Opuholi golovy i šei

Author:

Eremina A. O.¹^ORCID,Zaderenko I. A.²^ORCID,Ivanov S. Yu.³^ORCID,Alieva S. B.⁴^ORCID,Dymnikov A. B.¹^ORCID,Khromushina A. V.¹^ORCID,Pkheshkhova B. C.⁴^ORCID

Affiliation:

1. RUDN University

2. RUDN University; N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia

3. RUDN University; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia

4. N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia

Abstract

Oral mucositis is one of the most common effects of chemoradiotherapy in patients with oropharyngeal cancer. The development of oral mucositis is the main cause of interruption of antitumor therapy, which significantly affects the results of treatment of the main disease. Despite the fact that the disease is well studied in the literature, today there is no universal treatment and prevention protocol. The aim of this review is to analyze scientific publications devoted to the problems of etiology, pathogenesis, clinic, diagnosis, treatment and prevention of oral mucositis.

Publisher

Publishing House ABV Press

Subject

Pharmacology (medical),Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Otorhinolaryngology,Surgery

Reference107 articles.

1. Malignant tumors in Russia in 2017 (morbidity and mortality). Ed. by A.D. Kaprin, V.V. Starinsky, G.V. Petrova. Moscow: MNIOI im. P.A. Gertzena, 2018. 250 p. Available at: https://glavonco.ru/cancer_register/Забол_2018_Электр.pdf. (In Russ.).

2. Kanaev S.V. Principles and justification of chemoradiotherapy of malignant tumors. Practical oncology 2008;9(1):1–8. (In Russ.).

3. Langendijk J.A., Leemans C.R., Buter J. The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: a metaanalysis of the published literature. J Clin Oncol 2004;22(22):4604–12. DOI: 10.1200/JCO.2004.10.074.

4. Trotti A., Bellm L.A., Epstein J.B. et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol 2003;66(3):253–62. DOI: 10.1016/s0167-8140(02)00404-8.

5. Sonis S.T. Efficacy of palifermin (keratinocyte growth factor-1) in the amelioration of oral mucositis. Core Evid 2010;4:199–205. DOI: 10.2147/ce.s5995.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dental manifestations of antitumor therapy: literature review and practical recommendations;Russian Journal of Dentistry;2024-07-02

2. The possibilities of accompanying therapy for malignant oropharyngeal neoplasms;Onkologiya. Zhurnal imeni P.A.Gertsena;2023

3. Personalized or unified approach in the prevention and treatment of oral mucositis in patients with malignant neoplasms of the head and neck organs: the choice of the optimal solution;Head and Neck Tumors (HNT);2022-12-13

4. Low-level laser therapy in oncology — what’s new? Analysis of 2018—2021 publications;Voprosy kurortologii, fizioterapii i lechebnoi fizicheskoi kul'tury;2022

5. DYNAMICS OF CYTOKINE PROFILE IN CANCER PATIENTS WITH CHEMO-RAY ORAL MUCOSITIS DURING TREATMENT;Actual problems in dentistry;2021-08-12